metformin and Schistosomiasis mansoni
metformin has been researched along with Schistosomiasis mansoni in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Metformin (Met) is a well-known drug for type 2 diabetes." | 1.62 | An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice. ( El-Naggar, SA; El-Said, KS; Harras, SF; Salama, WM, 2021) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Salama, WM | 1 |
El-Naggar, SA | 1 |
Harras, SF | 1 |
El-Said, KS | 1 |
Other Studies
1 other study available for metformin and Schistosomiasis mansoni
Article | Year |
---|---|
An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice.
Topics: Adjuvants, Pharmaceutic; Animals; Anthelmintics; Diabetes Mellitus, Type 2; Fibrosis; Granuloma; Mal | 2021 |